Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthetic Approaches to the New Drugs Approved During 2017
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 16, pp. 7340-7382
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

AiZynthFinder: a fast, robust and flexible open-source software for retrosynthetic planning
Samuel Genheden, Amol Thakkar, Veronika Chadimová, et al.
Journal of Cheminformatics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 227
Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical Indication, Pharmacology, and Synthesis
Cecilia C. Ayala-Aguilera, Teresa Valero, Álvaro Lorente‐Macías, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 2, pp. 1047-1131
Open Access | Times Cited: 191
FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application
Shuai Wang, Xiaohan Yuan, Saiqi Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 214, pp. 113218-113218
Closed Access | Times Cited: 107
Datasets and their influence on the development of computer assisted synthesis planning tools in the pharmaceutical domain
Amol Thakkar, Thierry Kogej, Jean‐Louis Reymond, et al.
Chemical Science (2019) Vol. 11, Iss. 1, pp. 154-168
Open Access | Times Cited: 125
Quest for a COVID-19 Cure by Repurposing Small-Molecule Drugs: Mechanism of Action, Clinical Development, Synthesis at Scale, and Outlook for Supply
Chris De Savi, David L. Hughes, Lisbet Kværnø
Organic Process Research & Development (2020) Vol. 24, Iss. 6, pp. 940-976
Open Access | Times Cited: 97
Continuous flow asymmetric synthesis of chiral active pharmaceutical ingredients and their advanced intermediates
Sándor B. Ötvös, C. Oliver Kappe
Green Chemistry (2021) Vol. 23, Iss. 17, pp. 6117-6138
Open Access | Times Cited: 82
A decennary update on applications of metal nanoparticles (MNPs) in the synthesis of nitrogen- and oxygen-containing heterocyclic scaffolds
Tejas M. Dhameliya, Hiren A. Donga, Punit V. Vaghela, et al.
RSC Advances (2020) Vol. 10, Iss. 54, pp. 32740-32820
Open Access | Times Cited: 71
AiZynthFinder 4.0: developments based on learnings from 3 years of industrial application
Lakshidaa Saigiridharan, Alan Kai Hassen, Helen Lai, et al.
Journal of Cheminformatics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Decomposition of Ruthenium Olefin Metathesis Catalyst
Magdalena Jawiczuk, Anna Marczyk, Bartosz Trzaskowski
Catalysts (2020) Vol. 10, Iss. 8, pp. 887-887
Open Access | Times Cited: 66
A comprehensive survey upon diverse and prolific applications of chitosan-based catalytic systems in one-pot multi-component synthesis of heterocyclic rings
Hossein Mousavi
International Journal of Biological Macromolecules (2021) Vol. 186, pp. 1003-1166
Closed Access | Times Cited: 49
Azetidines of pharmacological interest
Deepa R. Parmar, Jigar Y. Soni, Ramakrishna Guduru, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 11
Closed Access | Times Cited: 44
Synthetic Approaches to the New Drugs Approved During 2020
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9607-9661
Closed Access | Times Cited: 29
Synthetic Approaches to New Drugs Approved During 2016
Andrew C. Flick, Hong X. Ding, Carolyn A. Leverett, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 16, pp. 7004-7031
Closed Access | Times Cited: 56
Synthetic Approaches to the New Drugs Approved during 2019
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 7, pp. 3604-3657
Closed Access | Times Cited: 36
Synthetic Approaches to the New Drugs Approved During 2021
Emma L. McInturff, Scott P. France, Carolyn A. Leverett, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10150-10201
Closed Access | Times Cited: 15
Recent advances in multitarget-directed ligands via in silico drug discovery
Maddeboina Krishnaiah, Bharath Yada, Shikha Kumari, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103904-103904
Closed Access | Times Cited: 5
Quantifying the ability of the CF2H group as a hydrogen bond donor
Matthew E Paolella, Daniel S. Honeycutt, Bradley M. Lipka, et al.
Beilstein Journal of Organic Chemistry (2025) Vol. 21, pp. 189-199
Open Access
EXPLORING AZETIDINE CONTAINING HETEROCYCLES: FROM GREEN SYNTHESIS TO APPLICATIONS
Shivangi Jaiswal, Nikhilesh Arya, Dharma Kishore, et al.
Tetrahedron (2025), pp. 134491-134491
Closed Access
Blue‐Light‐Induced Stereoselective Synthesis of α‐Alkylated Amino Acid Derivatives
Hongying Fan, Meiling Ye, Xue Zhang, et al.
European Journal of Organic Chemistry (2025)
Closed Access
Cu-Catalyzed α-Alkylation of Glycine Derivatives for C(sp3)–H/C(sp3)–H Bond Selective Functionalization
Huan Xiang, Yang Ye
ACS Catalysis (2023) Vol. 14, Iss. 1, pp. 522-532
Closed Access | Times Cited: 10
Synthesis and clinical application of new drugs approved by FDA in 2022
Jingyi Zhang, Yatao Wang, Lu Sun, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Catalytic Electrosynthesis of N,O‐Heterocycles – Recent Advances
Анна В. Листратова, Najoua Sbei, Leonid G. Voskressensky
European Journal of Organic Chemistry (2020) Vol. 2020, Iss. 14, pp. 2012-2027
Closed Access | Times Cited: 23
Kinetic Protection of a Water‐Soluble Olefin Metathesis Catalyst for Potential Use under Biological Conditions
Catriona C. James, Petrus C. M. Laan, Bas de Bruin, et al.
ChemCatChem (2023) Vol. 15, Iss. 7
Open Access | Times Cited: 7
The Asymmetric Petasis Borono-Mannich Reaction: Insights on the Last 15 Years
Carolina S. Marques, Pedro Brandão
Catalysts (2023) Vol. 13, Iss. 6, pp. 1022-1022
Open Access | Times Cited: 7
Discovery of novel biphenyl-sulfonamide analogues as NLRP3 inflammasome inhibitors
Chao Huang, Jinyu Liu, Yuxin Chen, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107263-107263
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top